D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overview All 13F holders of RNAC Full Q2 2026 holdings

Shares (Q2 2026): 28,651
Value: $298.5K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2021

Holdings of RNAC by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	28,651	$298.5K	<0.1%	+28,651	New	Holders
Q2 2021	0	$0	0.0%	−71,376−100.0%	Sold out	Holders
Q1 2021	71,376	$323.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.